Lv3
258 积分 2023-02-09 加入
Structure-based decoupling of the pro- and anti-inflammatory functions of interleukin-10
1天前
已完结
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials
1个月前
已完结
Risankizumab for Ulcerative Colitis
2个月前
已完结
Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial
2个月前
已完结
Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial
2个月前
已完结
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
2个月前
已完结
Interleukin-23 biology linking mucosal immunity to autoimmune diseases and cancer
2个月前
已完结
Selective inhibition of IL-6 trans-signaling by a miniaturized, optimized chimeric soluble gp130 inhibits T H 17 cell expansion
2个月前
已完结
Characterization of B and plasma cells in blood, bone marrow, and secondary lymphoid organs of rhesus macaques by multicolor flow cytometry
2个月前
已完结
Anti-CD20/CD3 T cell–dependent bispecific antibody for the treatment of B cell malignancies
2个月前
已完结
皖公网安备34019202002308
